Medical Journals

Pten Dependence Distinguishes Haematopoietic Stem Cells from Leukaemia-initiating Cells.

Authors:
  • Yilmaz Omer H
  • Valdez Riccardo
  • Theisen Brian K
  • Guo Wei
  • Ferguson David O
  • Wu Hong
  • Morrison Sean J

From: Howard Hughes Medical Institute, Life Sciences Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA.

Nature

  • Publish Date: May 2006
  • ISSN: 1476-4687
  • Volume: 441
  • Issue: 7092
  • Pages: 475-82
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Yilmaz Omer H, Valdez Riccardo, Theisen Brian K, et al. Pten Dependence Distinguishes Haematopoietic Stem Cells from Leukaemia-initiating Cells.. Nature May 2006;441:475-82

Abstract

Recent advances have highlighted extensive phenotypic and functional similarities between normal stem cells and cancer stem cells. This raises the question of whether disease therapies can be developed that eliminate cancer stem cells without eliminating normal stem cells. Here we address this issue by conditionally deleting the Pten tumour suppressor gene in adult haematopoietic cells. This led to myeloproliferative disease within days and transplantable leukaemias within weeks. Pten deletion also promoted haematopoietic stem cell (HSC) proliferation. However, this led to HSC depletion via a cell-autonomous mechanism, preventing these cells from stably reconstituting irradiated mice. In contrast to leukaemia-initiating cells, HSCs were therefore unable to maintain themselves without Pten. These effects were mostly mediated by mTOR as they were inhibited by rapamycin. Rapamycin not only depleted leukaemia-initiating cells but also restored normal HSC function. Mechanistic differences between normal stem cells and cancer stem cells can thus be targeted to deplete cancer stem cells without damaging normal stem cells.

Mesh Headings (Keywords): Animals, Cell Count, Cell Proliferation, Hematopoietic Stem Cells, Leukemia, Mice, Mice, Inbred C57BL, Neoplasm Transplantation, Neoplastic Stem Cells, PTEN Phosphohydrolase, Protein Kinases, Sirolimus


Check for Full Text / PubMed Unique Identifier (PMID): 16598206


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.